Pancreatic Resection in Veterans Affairs and Selected University Medical Centers

Results of the Patient Safety in Surgery Study

Robert E. Glasgow, Heidi H. Jackson, Leigh A Neumayer, Tracy L. Schifftner, Shukri F. Khuri, William G. Henderson, Sean J. Mulvihill

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Pancreatectomy is a high-risk, technically demanding operation associated with substantial perioperative morbidity and mortality. This study aims to describe the 30-day morbidity and mortality for pancreatectomy and to compare outcomes between private-sector and Veterans Affairs hospitals using multiinstitutional data. Study Design: This is a retrospective review of patients who underwent pancreatic resection for neoplasia at private-sector (PS) and Veterans Affairs (VA) hospitals participating in the National Surgical Quality Improvement Program Patient Safety in Surgery Study in fiscal years 2002 to 2004. The variables reviewed were demographics, preoperative medical conditions, intraoperative variables, and outcomes. Using logistic regression to control for differences in patient comorbidities, 30-day mortality and morbidity rates between PS and VA hospitals were compared. Results: A total of 1,069 patients underwent pancreatectomy for neoplasia at 97 participating hospitals. Six hundred ninety-two patients were treated at PS hospitals and 377 at VA hospitals. The average number of patients treated at each hospital was 11.0, with a range of 1 to 83 during the 3-year study period. There were 842 patients who underwent pancreaticoduodenectomy (CPT 4815x) and 227 who underwent distal/subtotal pancreatectomy (CPT 4814x). Significant differences were observed between PS patients and VA patients with regard to comorbidities and patient demographics. The 30-day unadjusted morbidity rate was 33.8% overall, 42.2% at VA hospitals versus 29.1% at PS hospitals (p < 0.0001). Unadjusted and adjusted odds ratio (OR) for postoperative morbidity comparing VA with PS hospitals was 1.781 (95% CI, 1.369-2.318) and 1.581 (95% CI, 1.064-2.307). The 30-day unadjusted operative mortality rate was 3.8% overall, 6.4% at VA hospitals and 2.5% at PS hospitals (p = 0.0015). Unadjusted and adjusted OR for postoperative mortality was 2.909 (95% CI, 1.525-5.549) and 2.533 (95% CI, 1.020-6.290), respectively. Similar outcomes were observed when looking at pancreaticoduodenectomy (CPT 4815x) when analyzed independent of other types of pancreatic resections. Conclusion: Pancreatectomies are high-risk operations with substantial perioperative morbidity and mortality. Risk-adjusted outcomes for patients treated at PS hospitals were found to be superior to those for patients treated at VA hospitals in the study.

Original languageEnglish (US)
Pages (from-to)1252-1260
Number of pages9
JournalJournal of the American College of Surgeons
Volume204
Issue number6
DOIs
StatePublished - Jun 2007
Externally publishedYes

Fingerprint

Veterans
Patient Safety
Private Sector
Veterans Hospitals
Private Hospitals
Pancreatectomy
Morbidity
Mortality
Pancreaticoduodenectomy
Comorbidity
Odds Ratio
Demography
Quality Improvement
Neoplasms
Logistic Models

ASJC Scopus subject areas

  • Surgery

Cite this

Pancreatic Resection in Veterans Affairs and Selected University Medical Centers : Results of the Patient Safety in Surgery Study. / Glasgow, Robert E.; Jackson, Heidi H.; Neumayer, Leigh A; Schifftner, Tracy L.; Khuri, Shukri F.; Henderson, William G.; Mulvihill, Sean J.

In: Journal of the American College of Surgeons, Vol. 204, No. 6, 06.2007, p. 1252-1260.

Research output: Contribution to journalArticle

Glasgow, Robert E. ; Jackson, Heidi H. ; Neumayer, Leigh A ; Schifftner, Tracy L. ; Khuri, Shukri F. ; Henderson, William G. ; Mulvihill, Sean J. / Pancreatic Resection in Veterans Affairs and Selected University Medical Centers : Results of the Patient Safety in Surgery Study. In: Journal of the American College of Surgeons. 2007 ; Vol. 204, No. 6. pp. 1252-1260.
@article{32e68ea212444f4abf3d7bf61ad8be96,
title = "Pancreatic Resection in Veterans Affairs and Selected University Medical Centers: Results of the Patient Safety in Surgery Study",
abstract = "Background: Pancreatectomy is a high-risk, technically demanding operation associated with substantial perioperative morbidity and mortality. This study aims to describe the 30-day morbidity and mortality for pancreatectomy and to compare outcomes between private-sector and Veterans Affairs hospitals using multiinstitutional data. Study Design: This is a retrospective review of patients who underwent pancreatic resection for neoplasia at private-sector (PS) and Veterans Affairs (VA) hospitals participating in the National Surgical Quality Improvement Program Patient Safety in Surgery Study in fiscal years 2002 to 2004. The variables reviewed were demographics, preoperative medical conditions, intraoperative variables, and outcomes. Using logistic regression to control for differences in patient comorbidities, 30-day mortality and morbidity rates between PS and VA hospitals were compared. Results: A total of 1,069 patients underwent pancreatectomy for neoplasia at 97 participating hospitals. Six hundred ninety-two patients were treated at PS hospitals and 377 at VA hospitals. The average number of patients treated at each hospital was 11.0, with a range of 1 to 83 during the 3-year study period. There were 842 patients who underwent pancreaticoduodenectomy (CPT 4815x) and 227 who underwent distal/subtotal pancreatectomy (CPT 4814x). Significant differences were observed between PS patients and VA patients with regard to comorbidities and patient demographics. The 30-day unadjusted morbidity rate was 33.8{\%} overall, 42.2{\%} at VA hospitals versus 29.1{\%} at PS hospitals (p < 0.0001). Unadjusted and adjusted odds ratio (OR) for postoperative morbidity comparing VA with PS hospitals was 1.781 (95{\%} CI, 1.369-2.318) and 1.581 (95{\%} CI, 1.064-2.307). The 30-day unadjusted operative mortality rate was 3.8{\%} overall, 6.4{\%} at VA hospitals and 2.5{\%} at PS hospitals (p = 0.0015). Unadjusted and adjusted OR for postoperative mortality was 2.909 (95{\%} CI, 1.525-5.549) and 2.533 (95{\%} CI, 1.020-6.290), respectively. Similar outcomes were observed when looking at pancreaticoduodenectomy (CPT 4815x) when analyzed independent of other types of pancreatic resections. Conclusion: Pancreatectomies are high-risk operations with substantial perioperative morbidity and mortality. Risk-adjusted outcomes for patients treated at PS hospitals were found to be superior to those for patients treated at VA hospitals in the study.",
author = "Glasgow, {Robert E.} and Jackson, {Heidi H.} and Neumayer, {Leigh A} and Schifftner, {Tracy L.} and Khuri, {Shukri F.} and Henderson, {William G.} and Mulvihill, {Sean J.}",
year = "2007",
month = "6",
doi = "10.1016/j.jamcollsurg.2007.03.015",
language = "English (US)",
volume = "204",
pages = "1252--1260",
journal = "Journal of the American College of Surgeons",
issn = "1072-7515",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Pancreatic Resection in Veterans Affairs and Selected University Medical Centers

T2 - Results of the Patient Safety in Surgery Study

AU - Glasgow, Robert E.

AU - Jackson, Heidi H.

AU - Neumayer, Leigh A

AU - Schifftner, Tracy L.

AU - Khuri, Shukri F.

AU - Henderson, William G.

AU - Mulvihill, Sean J.

PY - 2007/6

Y1 - 2007/6

N2 - Background: Pancreatectomy is a high-risk, technically demanding operation associated with substantial perioperative morbidity and mortality. This study aims to describe the 30-day morbidity and mortality for pancreatectomy and to compare outcomes between private-sector and Veterans Affairs hospitals using multiinstitutional data. Study Design: This is a retrospective review of patients who underwent pancreatic resection for neoplasia at private-sector (PS) and Veterans Affairs (VA) hospitals participating in the National Surgical Quality Improvement Program Patient Safety in Surgery Study in fiscal years 2002 to 2004. The variables reviewed were demographics, preoperative medical conditions, intraoperative variables, and outcomes. Using logistic regression to control for differences in patient comorbidities, 30-day mortality and morbidity rates between PS and VA hospitals were compared. Results: A total of 1,069 patients underwent pancreatectomy for neoplasia at 97 participating hospitals. Six hundred ninety-two patients were treated at PS hospitals and 377 at VA hospitals. The average number of patients treated at each hospital was 11.0, with a range of 1 to 83 during the 3-year study period. There were 842 patients who underwent pancreaticoduodenectomy (CPT 4815x) and 227 who underwent distal/subtotal pancreatectomy (CPT 4814x). Significant differences were observed between PS patients and VA patients with regard to comorbidities and patient demographics. The 30-day unadjusted morbidity rate was 33.8% overall, 42.2% at VA hospitals versus 29.1% at PS hospitals (p < 0.0001). Unadjusted and adjusted odds ratio (OR) for postoperative morbidity comparing VA with PS hospitals was 1.781 (95% CI, 1.369-2.318) and 1.581 (95% CI, 1.064-2.307). The 30-day unadjusted operative mortality rate was 3.8% overall, 6.4% at VA hospitals and 2.5% at PS hospitals (p = 0.0015). Unadjusted and adjusted OR for postoperative mortality was 2.909 (95% CI, 1.525-5.549) and 2.533 (95% CI, 1.020-6.290), respectively. Similar outcomes were observed when looking at pancreaticoduodenectomy (CPT 4815x) when analyzed independent of other types of pancreatic resections. Conclusion: Pancreatectomies are high-risk operations with substantial perioperative morbidity and mortality. Risk-adjusted outcomes for patients treated at PS hospitals were found to be superior to those for patients treated at VA hospitals in the study.

AB - Background: Pancreatectomy is a high-risk, technically demanding operation associated with substantial perioperative morbidity and mortality. This study aims to describe the 30-day morbidity and mortality for pancreatectomy and to compare outcomes between private-sector and Veterans Affairs hospitals using multiinstitutional data. Study Design: This is a retrospective review of patients who underwent pancreatic resection for neoplasia at private-sector (PS) and Veterans Affairs (VA) hospitals participating in the National Surgical Quality Improvement Program Patient Safety in Surgery Study in fiscal years 2002 to 2004. The variables reviewed were demographics, preoperative medical conditions, intraoperative variables, and outcomes. Using logistic regression to control for differences in patient comorbidities, 30-day mortality and morbidity rates between PS and VA hospitals were compared. Results: A total of 1,069 patients underwent pancreatectomy for neoplasia at 97 participating hospitals. Six hundred ninety-two patients were treated at PS hospitals and 377 at VA hospitals. The average number of patients treated at each hospital was 11.0, with a range of 1 to 83 during the 3-year study period. There were 842 patients who underwent pancreaticoduodenectomy (CPT 4815x) and 227 who underwent distal/subtotal pancreatectomy (CPT 4814x). Significant differences were observed between PS patients and VA patients with regard to comorbidities and patient demographics. The 30-day unadjusted morbidity rate was 33.8% overall, 42.2% at VA hospitals versus 29.1% at PS hospitals (p < 0.0001). Unadjusted and adjusted odds ratio (OR) for postoperative morbidity comparing VA with PS hospitals was 1.781 (95% CI, 1.369-2.318) and 1.581 (95% CI, 1.064-2.307). The 30-day unadjusted operative mortality rate was 3.8% overall, 6.4% at VA hospitals and 2.5% at PS hospitals (p = 0.0015). Unadjusted and adjusted OR for postoperative mortality was 2.909 (95% CI, 1.525-5.549) and 2.533 (95% CI, 1.020-6.290), respectively. Similar outcomes were observed when looking at pancreaticoduodenectomy (CPT 4815x) when analyzed independent of other types of pancreatic resections. Conclusion: Pancreatectomies are high-risk operations with substantial perioperative morbidity and mortality. Risk-adjusted outcomes for patients treated at PS hospitals were found to be superior to those for patients treated at VA hospitals in the study.

UR - http://www.scopus.com/inward/record.url?scp=34249339403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249339403&partnerID=8YFLogxK

U2 - 10.1016/j.jamcollsurg.2007.03.015

DO - 10.1016/j.jamcollsurg.2007.03.015

M3 - Article

VL - 204

SP - 1252

EP - 1260

JO - Journal of the American College of Surgeons

JF - Journal of the American College of Surgeons

SN - 1072-7515

IS - 6

ER -